Pharmacoepidemiology and Risk Management Solutions

Post-authorization safety and efficacy studies (PASS/PAES)

We have been contributing to the development and execution of PASS/PAES for several products from various therapeutic areas as part of the PV activities required for products in Europe, following PRAC referrals.

We can support you in all steps of the design and running of such studies. We have also been coordinating a consortium of companies having to perform a PASS on a class of products, consisting of 18 companies with over 150 products throughout Europe, with 7 data sources in 5 countries, one specialist pharmacoepidemiology partner, and including the communication with the PRAC and national competent authorities. Having gained the experience of running such an industry consortium with many important learnings along the way puts us in a unique position in the industry to set-up and successfully coordinate similar consortium approaches to safety and efficacy studies. We follow the ENCePP guide on methodological standards in pharmacoepidemiology and the ENCePP Code of Conduct.

This site uses cookies to personalise and customise your experience. No cookies collect personal or sensitive information. By clicking “I Accept", you consent to cookies in accordance with our cookie policy.